Get notified when ESI files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Merger Termination Fee ($376m) (new) — If the Solstice merger agreement is terminated under certain conditions, ESI would owe a $376M termination fee, potentially requiring drawdown on the revolving credit facility and reducing cash available for operations.
- Business Restrictions During Merger Pendency (new) — ESI cannot pursue strategic transactions, significant financing actions, or new business opportunities without Solstice consent while the merger is pending, potentially causing the company to forego beneficial opportunities.
- Merger Consideration Volatility (new) — The value of the Solstice stock consideration (0.5 shares per ESI share) may fluctuate materially before or after closing based on factors outside ESI's control, creating uncertainty about the ultimate value stockholders will receive.
Element Solutions agrees to Solstice merger (0.5 shares + $10 cash) as debt rises to $2.1B
Filed July 28, 2026 · Period ending June 30, 2026 · Compared to 10-Q Jul 31, 2025 · ~2 min read
Key Changes
-
high
Definitive merger agreement with Solstice announced July 6, 2026: ESI shareholders receive 0.5 Solstice shares plus $10.00 cash per share. Expected close H1 2027, subject to shareholder votes, SEC registration, Nasdaq listing, and HSR clearance. $376M termination fee if deal breaks under certain conditions.
Notes: Pending Solstice merger transaction view on EDGAR → -
high
Total debt increased from $1.62B to $2.12B at June 30, 2026, driven by $450M Add-on Term Loans to fund Micromax acquisition ($494M) and EFC acquisition ($367M). Revolver upsized from $375M to $500M with $50M drawn. Interest expense rose $11.1M in Q2 on higher principal and revolver borrowings.
MD&A: Debt increase from acquisitions verify on EDGAR → -
high
Q2 FY26 reported revenue growth accelerated to 56% (15% organic) from Q2 FY25's 2% reported (6% organic), driven by $107M pass-through metals pricing, $129M from Micromax, and $16.1M from EFC. Adjusted EBITDA rose 35% to $183.5M on acquisition contributions and organic volume growth.
MD&A: Q2 revenue growth verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (IMMR 10-K) is open in full — no account needed.
Partner
Trade ESI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 29, 2026 · How we verify